DEV Community

Ruslan Averin
Ruslan Averin

Posted on • Originally published at rfc-base.org

Palantir (PLTR) Failed at the 200-Day Line — When a 144 P/E Meets a Bad Chart

Analysis by Ruslan Averin — originally published at rfc-base.org.

Palantir (NASDAQ:PLTR) slipped again on June 12, and the tell was technical before it was fundamental.

By Ruslan Averin.

This is Ruslan Averin's PLTR stock analysis — here is how I read a failed breakout in one of the market's most expensive names.

The setup that broke

Palantir tried to clear its 200-day moving average and the top of a descending triangle — and failed. That rejection sent it back to test support near $126.50, a level that now decides the next move. The stock trades more than 35% below its 52-week high of $207.52 and is down about 26% year to date.

None of that is a fundamental indictment. Q1 2026 revenue grew roughly 85% year over year with strong operating margins. The business is doing fine. The stock is the problem.

Why valuation is the whole story

At a P/E around 144, Palantir is priced for a future in which almost everything goes right for years. That works beautifully on the way up and brutally on the way down. When a stock carries that multiple, it has no cushion: a failed technical level, a soft macro headline, or a single cautious analyst note is enough to trigger a sharp correction, because there is no valuation floor to catch it. The fundamentals can be excellent and the stock can still fall 35% — that is exactly what a 144 multiple means.

How I read it

I separate the company from the security. Palantir the company is a genuine AI-era winner. Palantir the stock is a momentum vehicle trading at a multiple that requires perfection. A failed breakout in a name like this is not noise — it is the market testing whether buyers will still pay 144 times earnings without an upward catalyst. Right now, at the 200-day line, the answer was no.

Bottom line: Great company, demanding price. I watch the $126.50 support as the line that matters and treat PLTR as a valuation story, not a growth one. I do not hold the shares and am not advising anyone to buy or sell.


More market analysis by Ruslan Averin at rfc-base.org.

Top comments (0)